product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
CA9 (D47G3) Rabbit mAb
catalog :
5649
clonality :
monoclonal
host :
rabbit
conjugate :
nonconjugated
clone name :
D47G3
reactivity :
human
application :
western blot, immunohistochemistry, immunoprecipitation, immunohistochemistry - paraffin section
more info or order :
Cell Signaling Technology product webpage
citations: 3
Published Application/Species/Sample/DilutionReference
  • immunohistochemistry; human; 1:200
Kuroda N, Agatsuma Y, Tamura M, Martinek P, Hes O, Michal M. Sporadic renal hemangioblastoma with CA9, PAX2 and PAX8 expression: diagnostic pitfall in the differential diagnosis from clear cell renal cell carcinoma. Int J Clin Exp Pathol. 2015;8:2131-8 pubmed
Karashima T, Kuno T, Kuroda N, Satake H, Fukata S, Chikazawa M, et al. Bilateral Xp11.2 translocation renal cell carcinoma: a case report. BMC Urol. 2018;18:106 pubmed publisher
Kuroda N, Furuya M, Nagashima Y, Gotohda H, Moritani S, Kawakami F, et al. Intratumoral peripheral small papillary tufts: a diagnostic clue of renal tumors associated with Birt-Hogg-Dubé syndrome. Ann Diagn Pathol. 2014;18:171-6 pubmed publisher
product information
SKU :
5649S
Product-Name :
CA9 (D47G3) Rabbit mAb
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H
Applications :
Immunohistochemistry (Paraffin)
Product-Category :
Metabolism
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
35-58
Host :
Rabbit
Target :
CA9
Primary-Protein :
CA9
Alt-Names :
CA-IX,CA9,CAH9,CAIX,Carbonate dehydratase IX,Carbonic anhydrase 9,Carbonic anhydrase IX,G250,MN,Membrane antigen MN,P54/58N,RCC-associated antigen G250,RCC-associated protein G250,Renal cell carcinoma-associated antigen G250,carbonic dehydratase,pMW1
more info or order :
Cell Signaling Technology product webpage
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
https://www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.